Table 4.

Effect on numbness

Duration in Weeks	Study population with numbness
	Epalrestat (N = 115)		Methylcobalamin (N = 115)
	n	%	n	%
Baseline	98	85.2	99	86.1
4	*65	56.5	@*82	71.3
8	*34	29.6	@*55	47.8
12	*15	13.0	@*31	27.0

By Chi-Square Test,

^*P < 0.05 Significant,

^@Between Groups